ELISA results also showed that the level of UDP-GlcNAc significantly increased, but significantly reduced the levels of IL-1β and TNF-α upon GlcNAc supplementation in the astrocytes of AD mice (Fig. 8k–m). This evidence concerns the gene IL1B and Alzheimer disease.